The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19

Coronavirus disease 2019 (COVID-19) has emerged as a serious threat to global health. The disregulation of the phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/Akt/mTOR) cell signaling pathway observed in patients with COVID-19 has attracted attention for the possib...

Descripción completa

Detalles Bibliográficos
Autores principales: Basile, Maria Sofia, Cavalli, Eugenio, McCubrey, James, Hernández-Bello, Jorge, Muñoz-Valle, José Francisco, Fagone, Paolo, Nicoletti, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Post-Screen (Grey)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574122/
https://www.ncbi.nlm.nih.gov/pubmed/34763066
http://dx.doi.org/10.1016/j.drudis.2021.11.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574122/
https://www.ncbi.nlm.nih.gov/pubmed/34763066
http://dx.doi.org/10.1016/j.drudis.2021.11.002

Ejemplares similares